» Download Public Reports
34 reports
- Industry report
- January 2013
- 7 pages
... Forecast the global nebulizer market to grow at a cagr of 5.1 Percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in the incidence of lung ...
July 2012
... Ma, develops tiny, sustained release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years. Psivida is currently focused on treatment of chronic ...
March 2012
... First-to-file opportunities o establish manufacturing independence Focus on high technology barrier to entry manufacturing, and Manufacturing of novel drug delivery products; Solid dose ...
March 2012
... Perfectly aligned around emerging unmet needs market trends point to significant, increasing unmet needs in injectable drug delivery $15b injectable drug delivery device market in 2015, 12.3% Cagr ...
February 2012
... Infusorunifill select rita auto injectorezmix 6 investing in unilife now redefining the $10b injectable drug delivery system market sanofi paid $40mm to access unifill in two core classes to 2014 device portfolio ...
January 2012
... Of this technology, particularly as it pertains to large quantities of product weighing the drawbacks of spray freeze drying, including potential harm to product panellists: heiko schier, lectu ...
December 2011
... Beds facility 50+ Studies completed [n=40] Key equipments: Lcms 4 Generics Dosage forms P-iv anda S Ftf opportunities Api & drug intermediates drug ...
November 2011
... Countries Growing number of acute and chronic diseases Accelerating pace in drug development Growth in biotech drugs and generics Outsourcing trend of drug delivery and primary packaging ...
October 2011
... Listed life sciences company in the early stages of commercializing drug delivery applications based on its novel transdermal (drugs administered via skin) tpm - targeted penetration matrix technology. 4 ...
October 2011
... Diverse revenue opportunities revenues will be driven through various channels " partnering and licensing in drug delivery tpm/oxycodone patch diclofenac dermatology " partnering and licensing ...
» Purchase Premium Reports
(From $ 75 - $ 4 650)
About 100 reports
- $ 4 650
- Industry report
- April 2013
- by MarketsandMarkets
The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal ...
April 2013
$ 4 650
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery ...
April 2013
$ 4 650
The global injectable drug delivery technologies market was valued at $22.5 billion in 2012, and is expected to reach $43.3 billion by 2017 at a CAGR of 14.0% from 2012 to 2017. Injectable drug delivery ...
April 2013
$ 2 732
Report Details Your guide to trends and revenue prospects for infusion pumps What does the future hold for the infusion pumps market? Visiongain's new report gives you forecasted revenues to 2023. It explains ...
March 2013
$ 2 000
TechNavio's analysts forecast the Global Smart Pill Technology market 2012-2016 to grow at a CAGR of 6.9 percent over the period 2012-2016. One of the key factors contributing to this market growth is ...
June 2013
$ 1 400
371 Million people had diabetes in 2012 and by 2030 this number is expected to rise to 552 Million. This finding by International Diabetes Federation (IDF) and similar results from studies done by organizations ...
May 2013
$ 250
Summary Respirics, Inc. (Respirics) is an inhalation drug products company. It is engaged in development and sale of therapeutic products for the healthcare markets. The company's product line consists ...
